These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 7804197)
21. Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates. Benincasa M; Scocchi M; Podda E; Skerlavaj B; Dolzani L; Gennaro R Peptides; 2004 Dec; 25(12):2055-61. PubMed ID: 15572192 [TBL] [Abstract][Full Text] [Related]
22. Polyene-resistance in yeasts: a consideration of physiological and biochemical mechanisms. Hamilton-Miller JM Microbios; 1973; 8(31):209-13. PubMed ID: 4589870 [No Abstract] [Full Text] [Related]
23. Sequence-selective binding to DNA of cis- and trans- butamidine analogues of the anti-Pneumocystis carinii pneumonia drug pentamidine. Bailly C; Donkor IO; Gentle D; Thornalley M; Waring MJ Mol Pharmacol; 1994 Aug; 46(2):313-22. PubMed ID: 8078493 [TBL] [Abstract][Full Text] [Related]
24. Characterization of the PNT1 pentamidine resistance gene of Saccharomyces cerevisiae. Ludewig G; Staben C Antimicrob Agents Chemother; 1994 Dec; 38(12):2850-6. PubMed ID: 7695273 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of anti-Pneumocystis agents using flow cytometry. Morley PJ; Dash L; Jackson HC J Eukaryot Microbiol; 1994; 41(5):105S-106S. PubMed ID: 7804199 [No Abstract] [Full Text] [Related]
26. Valinomycin affects the morphology of Candida albicans. Watanabe H; Azuma M; Igarashi K; Ooshima H J Antibiot (Tokyo); 2005 Dec; 58(12):753-8. PubMed ID: 16506692 [TBL] [Abstract][Full Text] [Related]
34. Biofilms of Candida albicans and their associated resistance to antifungal agents. Ramage G; Wickes BL; Lopez-Ribot JL Am Clin Lab; 2001 Aug; 20(7):42-4. PubMed ID: 11570274 [No Abstract] [Full Text] [Related]
35. [Fungicidal activity of cellobiose lipids from cultural fluid of yeast Cryptococcus humicola and Pseudozyma fusiformata]. Kulakovskaia EV; Kulakovskaia TV; Golubev VI; Shashkov AS; Grachev AA; Nifant'ev NE Bioorg Khim; 2007; 33(1):167-71. PubMed ID: 17375672 [TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus protease inhibitors and Pneumocystis carinii. Atzori C; Cargnel A J Infect Dis; 2002 Jun; 185(11):1692-3; author reply 1693-4. PubMed ID: 12023783 [No Abstract] [Full Text] [Related]
37. Cost-effectiveness models of clinical trials of new pharmaceuticals for AIDS-related Pneumocystis carinii pneumonia: are they helpful to policy makers? Bennett CL; Oddone E; Matchar D Clin Perform Qual Health Care; 1995; 3(3):156-64. PubMed ID: 10151167 [TBL] [Abstract][Full Text] [Related]
38. Modelling the inhibition of sorbic and benzoic acids on a native yeast cocktail from table olives. Arroyo-López FN; Bautista-Gallego J; Durán-Quintana MC; Garrido-Fernández A Food Microbiol; 2008 Jun; 25(4):566-74. PubMed ID: 18456111 [TBL] [Abstract][Full Text] [Related]
39. In vitro amoebicidal activity of propamidine and pentamidine isethionate against Acanthamoeba species and toxicity to corneal tissues. Alizadeh H; Silvany RE; Meyer DR; Dougherty JM; McCulley JP Cornea; 1997 Jan; 16(1):94-100. PubMed ID: 8985640 [TBL] [Abstract][Full Text] [Related]